An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress?

Mohit Khera; Trinity Bivalacqua; Irwin Goldstein; Maarten Albersen

doi:10.1016/j.euf.2019.05.017

An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress?

Mohit Khera, Trinity Bivalacqua, Irwin Goldstein, Maarten Albersen

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Regenerative cell-based therapy for erectile dysfunction is probably safe, and may be functionally beneficial. Currently, phase 2 trials are under way that we hope will provide a better insight into the efficacy of this regenerative therapy.

Original language	English (US)
Journal	European Urology Focus
DOIs	https://doi.org/10.1016/j.euf.2019.05.017
State	Published - Jan 1 2019

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.euf.2019.05.017

Fingerprint Dive into the research topics of 'An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress?'. Together they form a unique fingerprint.

Cite this

@article{91464709cd2f410997102a5fc1b782dd,

title = "An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress?",

abstract = "Regenerative cell-based therapy for erectile dysfunction is probably safe, and may be functionally beneficial. Currently, phase 2 trials are under way that we hope will provide a better insight into the efficacy of this regenerative therapy.",

author = "Mohit Khera and Trinity Bivalacqua and Irwin Goldstein and Maarten Albersen",

year = "2019",

month = jan,

day = "1",

doi = "10.1016/j.euf.2019.05.017",

language = "English (US)",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction

T2 - Have We Made Any Progress?

AU - Khera, Mohit

AU - Bivalacqua, Trinity

AU - Goldstein, Irwin

AU - Albersen, Maarten

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Regenerative cell-based therapy for erectile dysfunction is probably safe, and may be functionally beneficial. Currently, phase 2 trials are under way that we hope will provide a better insight into the efficacy of this regenerative therapy.

AB - Regenerative cell-based therapy for erectile dysfunction is probably safe, and may be functionally beneficial. Currently, phase 2 trials are under way that we hope will provide a better insight into the efficacy of this regenerative therapy.

UR - http://www.scopus.com/inward/record.url?scp=85066785896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066785896&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2019.05.017

DO - 10.1016/j.euf.2019.05.017

M3 - Comment/debate

C2 - 31196678

AN - SCOPUS:85066785896

JO - European Urology Focus

JF - European Urology Focus

SN - 2405-4569

ER -